Cargando…
Enzymatic- and temperature-sensitive controlled release of ultrasmall superparamagnetic iron oxides (USPIOs)
BACKGROUND: Drug and contrast agent delivery systems that achieve controlled release in the presence of enzymatic activity are becoming increasingly important, as enzymatic activity is a hallmark of a wide array of diseases, including cancer and atherosclerosis. Here, we have synthesized clusters of...
Autores principales: | Yu, Shann S, Scherer, Randy L, Ortega, Ryan A, Bell, Charleson S, O'Neil, Conlin P, Hubbell, Jeffrey A, Giorgio, Todd D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056743/ https://www.ncbi.nlm.nih.gov/pubmed/21352596 http://dx.doi.org/10.1186/1477-3155-9-7 |
Ejemplares similares
-
Enzymatic- and temperature-sensitive controlled release of ultrasmall superparamagnetic iron oxides (USPIOs)
por: Yu, Shann S, et al.
Publicado: (2011) -
Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes
por: Frascione, Daniela, et al.
Publicado: (2012) -
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents
por: Di Marco, Mariagrazia, et al.
Publicado: (2007) -
Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study
por: Pultrum, B.B., et al.
Publicado: (2009) -
In Vitro and In Vivo Detection of Drug-induced Apoptosis Using Annexin V-conjugated Ultrasmall Superparamagnetic Iron Oxide (USPIO): A Pilot Study
por: Nishie, Akihiro, et al.
Publicado: (2018)